BIOVERATIV
Live / Registered — Registered — Section 8 accepted (as of 12 Jan 2024)
What this means for you
Registered since 24 Oct 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87116555
- Registration number
- 5318162
- Mark type
- Stylized text
- Filed
- 26 Jul 2016
- Published for opposition
- 20 Dec 2016
- Registered
- 24 Oct 2017
- Attorney of record
- Karen Lim
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical drug development services
Owner
- BIOVERATIV THERAPEUTICS INC., WALTHAM, MA, US
- BIOVERATIV THERAPEUTICS INC., WALTHAM, MA, US
- BIOVERATIV THERAPEUTICS INC., CAMBRIDGE, MA, US
- Biogen Hemophilia Inc., Cambridge, MA, US
Prosecution history
- 12 Jan 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 12 Jan 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 12 Jan 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 30 Oct 2023 — TEAS SECTION 8 RECEIVED
- 24 Oct 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 10 Oct 2019 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 10 Oct 2019 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 24 Oct 2017 — REGISTERED-PRINCIPAL REGISTER
- 22 Sept 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 21 Sept 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 19 Sept 2017 — ASSIGNED TO EXAMINER
- 01 Sept 2017 — STATEMENT OF USE PROCESSING COMPLETE
- 14 Aug 2017 — USE AMENDMENT FILED
- 01 Sept 2017 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 14 Aug 2017 — TEAS STATEMENT OF USE RECEIVED